Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chemotherapy induces cell plasticity controlling plasticity increases therapeutic response.

ABSTRACT: Chemotherapy induces cell plasticity controlling plasticity increases therapeutic response.

PROVIDER: PRJNA955789 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24174914_1.fastq.gz	Fastqsanger.gz
	SRR24174914_2.fastq.gz	Fastqsanger.gz
	SRR24174915_1.fastq.gz	Fastqsanger.gz
	SRR24174915_2.fastq.gz	Fastqsanger.gz
	SRR24174916_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Chemotherapy induces cell plasticity; controlling plasticity increases therapeutic response.

Project description:One of the most serious issues in modern oncology is the ineffectiveness of treatments in destroying tumours, which leads to tumour recurrence and, ultimately, patient death To investigated this we analyze plasticity of chemotherapy-resistant cells

2024-04-09 | GSE229761 | GEO

Chemotherapy induces cell plasticity; controlling plasticity increases therapeutic response.

Project description: Not available

| S-EPMC10315372 | biostudies-literature

EMT-driven plasticity prospectively increases cell-cell variability to promote therapeutic adaptation in breast cancer

Project description:EMT-driven plasticity prospectively increases cell-cell variability to promote therapeutic adaptation in breast cancer

| PRJNA1098856 | ENA

Methionine Restriction Reduces Lung Cancer Progression and Increases Chemotherapy Response

Project description:Methionine Restriction Reduces Lung Cancer Progression and Increases Chemotherapy Response

| PRJNA1126222 | ENA

Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma I

Project description:Cancer stem cells (CSCs) drive tumour spread and therapeutic resistance, and can undergo epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) to switch between epithelial and post-EMT sub-populations. Examining oral squamous cell carcinoma (OSCC), we now show that increased phenotypic plasticity, the ability to undergo EMT/MET, underlies increased CSC therapeutic resistance within both the epithelial and post-EMT sub-populations. The post-EMT CSCs that possess plasticity exhibit particularly enhanced therapeutic resistance and are defined by a CD44highEpCAMlow/-CD24+ cell surface marker profile. Treatment with TGFÎ² and retinoic acid (RA) enabled enrichment of this sub-population for therapeutic testing, through which the endoplasmic reticulum (ER) stressor and autophagy inhibitor Thapsigargin was shown to selectively target these cells. Demonstration of the link between phenotypic plasticity and therapeutic resistance, and development of an in vitro method for enrichment of a highly resistant CSC sub-population, provides an opportunity for the development of improved chemotherapeutic agents that can eliminate CSCs. The CA1 OSCC cell line was sub-cloned to derive 4 clonal sub-lines, termed pEMT-P, pEMT-S, Epi-S and Epi-P (here 18, 23, 7 and 4 respectively).

2016-01-12 | E-GEOD-74578 | biostudies-arrayexpress

Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma II

Project description:Cancer stem cells (CSCs) drive tumour spread and therapeutic resistance, and can undergo epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) to switch between epithelial and post-EMT sub-populations. Examining oral squamous cell carcinoma (OSCC), we now show that increased phenotypic plasticity, the ability to undergo EMT/MET, underlies increased CSC therapeutic resistance within both the epithelial and post-EMT sub-populations. The post-EMT CSCs that possess plasticity exhibit particularly enhanced therapeutic resistance and are defined by a CD44highEpCAMlow/-CD24+ cell surface marker profile. Treatment with TGFÎ² and retinoic acid (RA) enabled enrichment of this sub-population for therapeutic testing, through which the endoplasmic reticulum (ER) stressor and autophagy inhibitor Thapsigargin was shown to selectively target these cells. Demonstration of the link between phenotypic plasticity and therapeutic resistance, and development of an in vitro method for enrichment of a highly resistant CSC sub-population, provides an opportunity for the development of improved chemotherapeutic agents that can eliminate CSCs. The clonal derivative of the CA1 OSCC cell line termed 18 here (otherwise termed pEMT-P) was treated with 0.5ng/ml TGFbeta and/or 5uM RA for eight days, with media changed every second day. The LM OSCC cell line was FACS sorted to recover the CD44highEpCAMlowCD24+ sub-population, which was then treated with 0.5ng/ml TGFbeta and/or 5uM RA for eight days, with media changed every second day. The parental CA1 and LM cell lines are included as reference samples.

2016-01-12 | E-GEOD-74580 | biostudies-arrayexpress

Impact of EMT-driven plasticity on phenotypic diversity dynamics under chemotherapy [organoids]

Project description:Triple negative breast cancer (TNBC) is the most lethal breast cancer subgroup, as lack of targeted therapies and drug resistance reduce survival rates. Cellular plasticity enables cells to adapt non-genetically and overcome therapeutic pressure, thereby embodying a critical clinical hurdle. The epithelial-mesenchymal transition (EMT) is an example of phenotypic reprogramming linked to plasticity, drug resistance and metastasis. However, its exact impact on population diversity under therapeutic pressure is unknown. Here, we used single cell transcriptomics to investigate phenotypic diversity dynamics upon drug treatment in two human in vitro models of TNBC plasticity.

2024-12-04 | GSE263728 | GEO

Impact of EMT-driven plasticity on phenotypic diversity dynamics under chemotherapy [spontaneous]

2024-12-04 | GSE263729 | GEO

Controlling therapeutic protein expression via inhalation of a butter flavor molecule

Project description:Controlling therapeutic protein expression via inhalation of a butter flavor molecule

| PRJNA899846 | ENA

Therapeutic Targeting of Epithelial Mesenchymal Cellular Plasticity in Pancreatic Cancer

Project description:Therapeutic Targeting of Epithelial Mesenchymal Cellular Plasticity in Pancreatic Cancer

| PRJNA1369942 | ENA